Sermorelin peptide buy guide: the legal route, 9 offers, and every listed fee
By Peptide Care Index · Offers and FDA records checked October 15, 2026
Sermorelin peptide buy options for U.S. patients start with a prescriber and a dispensing pharmacy. A prescription alone does not establish that an exact compounded product meets every rule. Nine published offers advertise prices from $70.95 to $349, but their forms, fees, and commitments differ. Research-use listings are not a patient-care route. (FDA compounding guidance; 503A conditions)
A "$99 a month" offer can lock you into $297 in payments or require a prepaid plan with an unstated upfront charge. A vial price can leave out nearly as much again in visit and shipping fees. Below, you'll see the main ways people try to buy sermorelin, nine real offers broken into known and missing charges, what happens to your money if you're turned down, and a seller check you can run before you pay.
The short version
- You need a prescription for the pharmacy-dispensed patient route. Section 503A provides a patient-specific compounding framework, subject to its ingredient and other conditions—not a blanket permission for every offer. (21 U.S.C. 353a)
- Geref isn't a current product you can buy. Its approvals were withdrawn in 2009, and the current FDA entries show it as discontinued. The offers below are compounded, and FDA says compounded drugs are not FDA-approved. (Federal Register, Mar 4, 2013; FDA product records; FDA compounding guidance)
- One advertised 15 mg vial plus review and shipping totals $134. That's the published-charge subtotal for one Rx Peps Direct order, not one upfront payment or a monthly treatment price. Its $39 review comes first; the $95 medication-and-shipping bill is separate if prescribed. (Our arithmetic from Rx Peps Direct, checked Oct 15, 2026)
- Two "$99" offers have bigger commitments. Bayan bills $99 monthly with a $297 minimum over 90 days. AgelessRx's injection offer requires a three-month plan paid in full but doesn't state the upfront total. (Bayan; AgelessRx)
- Research-use listings aren't patient-care offers. FDA has sent warning letters to such sellers, including one that listed sermorelin. (FDA's Xcel Research letter; our warning-letter register)
Sermorelin peptide buy options: 9 published offers compared
The useful comparison isn't the smallest number on a page. It's what each payment buys, what's charged now, what renews, and what's still unknown. These are advertised offers from eight sellers, not a ranking and not a recommendation to take sermorelin.
Table 1. Nine published U.S. sermorelin offers: what the price buys, known charges, and what's missing Provider-published terms, checked October 15, 2026. Listed alphabetically by seller. We didn't place orders, test checkout, or confirm terms with any seller. "Not stated" means unknown, not $0.
| Seller and form | What the headline price buys | Known charges | Commitment and renewal | Published first payment / calculated subtotal | Not stated or unresolved |
|---|---|---|---|---|---|
| AgelessRx — injection (offer, FAQ) | Clinician-guided plan; compounded product; strength and amount not stated | $99 for month one, which applies to a 3-month plan billed in full; $149/month after; free shipping; video visits at no extra cost (FAQ) | 3-month plan for the $99 price; a monthly plan is also offered | Upfront total not stated. $99 + $149 + $149 = $397 only if $149 applies to both remaining months. This is a conditional calculation, not a verified charge. | Amount charged today; strength and amount; labs; pharmacy name |
| AgelessRx — nasal spray (offer) | Monthly nasal spray plan; strength and amount not stated | $149 first month; $199/month after; shipping and ongoing support advertised | Monthly; pause or cancel anytime; service limited to people 30 and older | $149 advertised first-month price, not an independently tested checkout total | Strength and amount; labs; pharmacy name |
| Bayan Health — injection (offer) | Advertised 3-month supply shipped at once if approved: 10 mL at 0.9 mg/mL (9 mg, our calculation); Olympia named | $99/month, billed monthly for 3 months; clinician consult and expedited shipping included; no membership fee | 90-day protocol that Bayan says can't be cancelled during that period; then renews month to month | $99 at the first bill; $297 minimum over the 90-day commitment | Labs; refund if not approved or if the pharmacy cannot fill |
| Brello — injection (offer, refunds) | "3 Month" plan: medication if approved, syringes, provider review, shipping; strength and amount not stated | $349 billed today; advertised as $116/month | Renews at $349. The page says "every 11 weeks" in one place and "every 3 months" in another. | $349 advertised today; $698 across that charge and one unchanged renewal | Strength and amount; labs; which renewal interval applies; the page's FAQ names semaglutide instead of sermorelin |
| CareFirst Specialty Pharmacy — troche (offer) | Pharmacy only: compounded troches (dissolve in the mouth) in 200, 400, or 500 mcg; you need your own prescription | "As low as $70.95"; $19.95 per order for required ice-pack shipping | Per order | $90.90 conditional subtotal if the selected prescription qualifies for $70.95 ($70.95 + $19.95); not a complete care bill | Quantity and strength behind the $70.95; whether any other shipping applies; your prescriber's fees |
| Hone Health — injection (offer, Premium plan details) | Compounded sermorelin listed with Premium; strength and amount not stated | Product page: $175/month medication. Premium help page: $130/month estimated medication. Premium membership $155/month; initial at-lab test $65. Ongoing labs, consultations and shipping included in that plan; medication separate. | Monthly membership; cancellation takes effect at the end of the current billing period | $65 initial test is the stated starting step. Conditional first-month-plus-test sums are $350 or $395, depending on which medication figure applies; not a single verified checkout total. | Why the medication figures differ and which applies; final formulation and quantity; pharmacy name; denial-refund terms |
| Love My Peptides — injectable vial (pricing, refunds) | One 15 mg vial (5 mL at 3 mg/mL); policy names Optimal Balance Pharmacy | $120 vial + $99 first visit (includes a 30-day check-in) + $15 per shipment; syringes and swabs included; $99 yearly follow-up; $49 visit to add a medication to an existing plan | Per order; no membership | $234 first-order subtotal for a new patient ($120 + $99 + $15), across the visit and medication/shipping charges | How long a vial lasts; any additional labs or individualized requirements |
| Rx Peps Direct — injectable vial (offer, refunds) | One 15 mg vial (5 mL at 3 mg/mL); provider describes a Texas 503A pharmacy but does not name it on the offer page; advertises clinician coverage in 28 states plus D.C. | $80 vial + $39 review per order + $15 overnight shipping per order; supplies included | Per order; no membership | $39 review first; $134 first-order subtotal if prescribed ($80 + $39 + $15), with pharmacy charges separate | How long a vial lasts; labs; pharmacy name and its refund terms; whether your state and prescription are covered |
| Strut Health — lozenge (offer, cancellation) | 30 lozenges per refill; strength not stated | "Starting at $99"; online visit and shipping included | Monthly auto-refill; cancel at least 48 hours before the next refill is processed | Starting at $99; exact selected order not checked | Strength; labs; pharmacy name; denial-refund terms |
How to read Table 1
- These aren't equal packages. A 9 mg supply tied to a 90-day commitment, a 15 mg vial, a nasal spray, and a box of lozenges can't be ranked against each other on price.
- A vial isn't a month. How long any amount lasts depends on what's prescribed. We don't guess.
- Our totals add only the charges each seller names. Conditional totals are labeled. A missing required charge keeps a total incomplete.
- The website and the pharmacy can be different businesses. Bayan names Olympia, CareFirst is itself the named pharmacy, and Love My Peptides' refund policy names Optimal Balance Pharmacy. Rx Peps Direct gives a Texas location and a 503A description, not a pharmacy name. Naming a pharmacy still isn't a license or order-specific fulfillment check.
What the table shows
- For two vials with the same labeled amount, first-order subtotals differ by $100. Love My Peptides' subtotal is $234; Rx Peps Direct's is $134. Of that gap, $60 is the visit/review fee and $40 is the medicine. These labels don't establish identical finished formulations or care.
- "$99 a month" is three different deals. Bayan's is $297 over a locked 90 days, billed monthly. AgelessRx's injection price requires a prepaid plan with an unconfirmed upfront amount. Strut's $99 is a starting monthly refill price with an unstated strength.
- The cheapest-looking headline needs your own prescription. CareFirst's $70.95 starting troche price is a pharmacy sale only. If you don't already have a prescriber, add whatever that visit costs.
- Two providers have unresolved page conflicts. Brello lists two renewal intervals, and its FAQ names a different drug. Hone's product page and Premium help page show different medication prices. Ask which terms govern your order before you pay.
The table shows what each seller advertises. Your next step is to check the one offer you're actually considering: who prescribes, which pharmacy fills it, and what you'll owe today, at renewal, and if nothing is prescribed. Peptide Care Index's Find My Peptide Path tool has a dated sermorelin access summary, a provider check, and a fee checklist, with questions you can copy and send. Free to use. No signup required.
Which buying route fits where you are now?
Start with what you already have: a prescription, a need for an evaluation, or just a seller you found. Those are different jobs. Paying for one doesn't complete the others, and a research-use sale doesn't establish a prescription-care route.
Table 2. Common ways people try to buy sermorelin, and what each route actually gets you Checked October 15, 2026. Findings use the Peptide Care Access Check labels.
| Route | What you actually get | Access framework for a patient | Quality oversight to check | What to confirm first | Finding on the stated criterion |
|---|---|---|---|---|---|
| Online clinic, then a compounding pharmacy (e.g., AgelessRx, Bayan, Brello, Hone, Love My Peptides, Rx Peps Direct, Strut) | A clinician review, a prescription if approved, and a compounded product if the pharmacy accepts the order | Patient-specific dispensing under 503A conditions is one framework; any 503B supply has different requirements | The actual dispensing/preparing entity, applicable state licenses, and any claimed 503B registration; neither status approves the product | The pharmacy's name and license, the charge today, any lock-in, and the refund if you aren't prescribed | Supported for the advertised review-to-prescription workflow; the exact preparation's compliance remains Unresolved |
| Your own doctor or a local clinic | A clinical assessment and, if appropriate, a prescription sent for fulfillment | The same framework-specific conditions apply; a local address is not an exemption | The actual preparing and dispensing entities | Which pharmacy fills it, and what the visit and refills cost | Supported for the prescriber-to-pharmacy workflow in 503A; a specific local offer was not assessed |
| Compounding pharmacy with a prescription you already have (e.g., CareFirst) | The pharmacy considers your prescriber's order for fulfillment | 503A's conditions, not the prescription alone | The dispensing pharmacy | Whether it can fill your exact form and strength and ship to your state | Supported for CareFirst's advertised prescription/transfer process; prescriber costs are separate |
| "Research use only" website | A product offered for laboratory research rather than prescription dispensing | A research label supplies no patient-care authorization; see FDA's Xcel letter | A research label or seller-supplied test report does not establish licensed patient dispensing | Don't treat it as a substitute for a prescription-care offer | Not applicable as a patient-care offer |
| Overseas seller or personal import | A product offered for cross-border shipment; its identity and access basis are not established here | Not reviewed for this page | Not established | Applicable import rules, exact product and supplier—not just a prescription or customs delivery | Unresolved. We don't recommend it. |
| Geref advertised as a currently marketed "FDA-approved sermorelin" product | Historical product records, not current Geref supply | Geref approvals were withdrawn effective June 18, 2009; current FDA entries are discontinued (history; product records, treatment records) | Check an exact current FDA product record, not an ingredient-name claim | Is the offer actually compounded? | Contradicted for current Geref marketing status |
You already have a prescription
Ask a compounding pharmacy whether it can fill your exact prescription and ship it to your state. You don't have to join another clinic just to buy refills.
CareFirst Specialty Pharmacy, for example, says it will take a transferred prescription, contact your prescriber for you, or accept one by fax or mail (CareFirst). That's a fill, not a new care plan. Your prescriber stays the one who decides whether sermorelin is right for you. Before you switch pharmacies, get the pharmacy's name, a written quote for your exact form and amount, and its shipping cost. Troches there, for instance, add a $19.95 ice-pack charge per order.
You need an evaluation before a prescription
A paid review buys an assessment, not a guaranteed prescription. Check who reviews you, whether they can treat patients in your state, and which charges you lose if you're turned down.
The usual order goes like this: you pay a review fee or authorize a plan, a clinician reviews you, they decide whether to prescribe, a pharmacy accepts the order, and then it ships. Some sellers charge before the review and some after. Rx Peps Direct, for example, collects its $39 review up front and keeps it even if the provider says no (Rx Peps Direct refund policy). AgelessRx says it doesn't charge for the prescription until you're approved (AgelessRx FAQ).
A service's age cutoff is not a universal sermorelin eligibility rule; clinical judgment and state requirements still apply. AgelessRx's nasal spray page limits that service to people 30 and older. Rx Peps Direct says its clinicians are licensed in 28 states plus D.C. Bayan says it serves the whole country. Check your state against the exact treatment you want, not a general claim that a company "operates nationwide."
You can buy it "near me" too
You can ask your regular clinician or a local hormone clinic whether a prescription is appropriate and which pharmacy could fill it. The same checks apply: who prescribes, which pharmacy fills it, and the full bill. We didn't price local clinics, so we don't publish local averages. The patient-specific framework is in 21 U.S.C. 353a; it does not guarantee that a particular local clinician offers sermorelin.
What you'll actually pay: today, at renewal, and if you're turned down
Compare three numbers separately: what's charged now, what renews, and what you lose if nothing is prescribed. A pharmacy-only price, a first-month rate, and a prepaid plan aren't the same kind of number, so the lowest one isn't automatically the cheapest deal.
Worked example: one 15 mg vial from two sellers
Add only the charges a seller names for the same purchase. When a required item has no price, the total stays incomplete.
Table 3. Same labeled amount, two sellers: first order and second order (our arithmetic) Provider-published prices, checked October 15, 2026. Both sell one 5 mL vial labeled 3 mg/mL (15 mg). Subtotals exclude any applicable tax and additional labs or individualized charges not priced on these pages; they are not tested checkout totals.
| Charge | Love My Peptides | Rx Peps Direct |
|---|---|---|
| Vial | $120 | $80 |
| Visit or review | $99 first visit (one-time; $99 yearly follow-up after) | $39 per order |
| Shipping | $15 per shipment | $15 per order |
| First-order subtotal | $234 | $134 |
| Second order, same year (if no other charge applies) | $120 + $15 = $135 | $80 + $39 + $15 = $134 |
| Two-order subtotal, same year | $369 | $268 |
What this shows: the visit fee structure matters as much as the vial price. Love My Peptides lists an initial visit and an annual follow-up; Rx Peps Direct charges its review on every order. Love My Peptides also lists a $49 visit to add a medication to an existing plan; that fee is not part of this new-patient, same-medication example. After two orders the gap is $101. How quickly you'd need a second vial depends on the prescription, so we don't turn this into a monthly cost.
Sources: Love My Peptides pricing, Rx Peps Direct sermorelin, and our peptide price list.
What "$99 a month" commits you to
Two of the $99 offers aren't freely cancellable month-to-month deals. Bayan bills monthly but has a 90-day term it says you can't cancel, so the minimum is $297. AgelessRx's injection price applies to a three-month plan billed in full, and the page doesn't state that upfront amount.
- Bayan: $99 a month × 3 months = $297 minimum. Bayan says the 90-day protocol can't be cancelled during that period, and its advertised 3-month supply (10 mL × 0.9 mg/mL = 9 mg, our calculation) ships at once if you're approved. After 90 days it renews month to month. (Bayan)
- AgelessRx injection: The offer says $99 for the first month applies to a three-month plan billed in full, then $149 a month. Conditional example, not a quote: if the other two months are each $149, $99 + $149 + $149 = $397. The page does not state the amount authorized today. Ask for the selected plan's actual upfront amount. (AgelessRx)
- Brello: $349 is advertised today. Brello calls that "$116 a month"; our calculation, $349 ÷ 3, is about $116.33, not a monthly payment option. The renewal is another $349, at either 11 weeks or 3 months, depending on which part of the page you read. Two unchanged charges total $698. (Brello)
A monthly subscription can be easier to stop than a prepaid or locked term, but its cancellation cutoff still matters. Strut's lozenges and AgelessRx's nasal spray renew monthly. Strut asks for at least 48 hours before processing; Hone's membership cancellation takes effect at the end of the current billing period. (Strut; AgelessRx; Hone)
Membership and lab fees that sit beside the price
Hone's sermorelin product page displays a Premium tier badge and $175 a month for the medication. Its men's Premium help page instead lists compounded sermorelin at an estimated $130 a month, plus a $155 monthly membership and $65 initial at-lab test. Medication is billed separately. That plan includes ongoing labs, consultations, and shipping. The price difference is unresolved; it is not a reason to assume either number is your quote.
Conditional arithmetic, not a quote: $130 + $155 = $285 per month, or $175 + $155 = $330 per month, depending on the medication price that applies. Adding the $65 initial test gives $350 or $395 across the initial test and first month's membership and medication—not necessarily one payment. The $65 test is the stated starting step. Ask Hone which medication price and exact supply apply, and what happens to each charge if treatment isn't prescribed. Its membership overview lists a $25 Basic plan, but it does not establish that Basic includes sermorelin access.
None of the other eight offers prices a required lab. That doesn't mean there isn't one. "Labs not mentioned" is a question to ask, not a $0.
If you're turned down, or change your mind
A refund when a clinician declines you is a different event from a refund when you cancel. Read the policy for the exact moment you might want your money back.
Table 4. What happens to your money at each stage, by seller Published policies, checked October 15, 2026. Not a statement of every consumer right you may have.
| Seller | If you're not prescribed | If you cancel after a prescription, before it ships | After processing, dispensing or shipment |
|---|---|---|---|
| AgelessRx (FAQ) | Not charged for the prescription until approved | Cancel or pause before the next refill, preferably with 48 hours' notice. Refunds aren't guaranteed once the pharmacy has the order. | No returns or refunds once it leaves the pharmacy under the stated policy; contact support about an order problem |
| Bayan (offer) | Not stated in the offer, FAQ or terms reviewed | The published 90-day term says it can't be cancelled; a distinct no-fill/refund rule was not established | Not stated in the reviewed sources |
| Brello (refund policy) | Full refund if the provider declines treatment and no prescription is issued | Before dispensing, request within 24 hours of the prescription notification: refund minus a $50 professional-service fee | Non-refundable once dispensed under the policy; dispensing can happen before shipping |
| CareFirst (offer) | It requires an existing prescription; your prescriber's refund terms are separate | Not stated on the offer page checked | Not stated on the offer page checked |
| Hone (Premium plan, membership FAQ) | An explicit denial-refund rule was not established | Membership cancellation takes effect at the end of the current billing period; this does not establish a medication refund | Medication/refund outcome not established by these membership pages |
| Love My Peptides (policy) | Visit fee is nonrefundable once the visit begins, even if medication is declined. No medication charge if nothing is prescribed. | Medication can be cancelled for a full refund before the order is placed with the pharmacy; the completed visit fee remains separate | No medication cancellation or refund after pharmacy order placement under the policy; error, damage, warm delivery or loss has a stated replacement process |
| Rx Peps Direct (refund policy) | The $39 review is kept once review begins, even if you're denied | A pre-review refund request may be considered; after review begins that fee is nonrefundable. Medication refunds go through the pharmacy. | Handled by the pharmacy; its order-specific terms were not verified |
| Strut (cancellation, refund policy) | Not stated in the reviewed sources | Cancel at least 48 hours before the next refill is processed; no cancellation refund after pharmacy processing | No medication returns/refunds once it leaves the pharmacy under the policy; defective or damaged orders have a stated replacement process |
Never read "cancel anytime" as "refund anytime." Cancelling usually stops the next charge; it doesn't return the last one. Love My Peptides separately allows a full visit-fee refund when cancelled at least 24 hours before the appointment; later cancellation or a missed visit has a one-time rescheduling provision. Its pharmacy-error and shipment replacement policy asks for contact within 48 hours of delivery or expected delivery. Strut's published policy asks for damaged/defective-order contact within two weeks. Contact the official service promptly rather than treating this table as the full policy. (Love My Peptides; Strut)
Does insurance, an HSA, or an FSA pay?
The prices here are self-pay quotes, not verified insurance benefits. AgelessRx and Strut say they don't accept insurance (AgelessRx FAQ; Strut FAQ). An HSA or FSA badge is not proof that every charge qualifies for reimbursement. Hone, for example, calls its lab test HSA/FSA-eligible on the sermorelin page; that does not establish coverage of every sermorelin charge. Ask your plan before you count on it.
Is there a cheapest place to buy sermorelin?
Not one we can name honestly. These offers sell different forms, amounts, services, and commitments, so a single "cheapest" label would compare unlike things. Here's what the evidence does support:
- Lower first-order subtotal in the two disclosed 15 mg vial examples: Rx Peps Direct, $134 versus Love My Peptides' $234, using the named review/visit and shipping charges. Rx Peps Direct advertises 28 states plus D.C.; its $39 review is kept once review begins, even if you're denied. This is not a whole-market cheapest claim.
- A low pharmacy-only starting price: CareFirst's troches start at $70.95, plus the $19.95 ice-pack charge. The conditional $90.90 subtotal has an unconfirmed quantity and excludes your prescriber's fees and any other shipping. It cannot establish the lowest complete first bill.
- A disclosed monthly-billed commitment: Bayan, $297 across 90 days with consult and expedited shipping included. You can't cancel during that term under its published offer. This is a payment-structure distinction, not a claim that it includes more than every other plan.
The best price is the lowest complete quote for the prescription you actually get. Use the worksheet below to get one.
Sermorelin payment worksheet
Use this to get a complete written quote. It helps you compare the same prescribed product and service. It's not for choosing a dose.
| Field | What to write down |
|---|---|
| Product | Sermorelin alone or a named blend; the stated salt/formulation (such as sermorelin acetate); injection, nasal spray, troche, or lozenge |
| Amount | Strength, amount per container, number of containers. No assumed "month." |
| Clinical review | First charge, what it covers, and whether repeat reviews cost extra |
| Labs and follow-up | Which are required, their prices, who bills them, and whether outside results are accepted |
| Pharmacy and shipping | The pharmacy's name, dispensing charge, supplies, shipping, and any cold-pack charge |
| Commitment and renewal | Total charged now, minimum term, next charge amount and date, and the automatic-renewal rule |
| Cancellation | How to cancel, how far ahead, and what happens to unused prepaid supply |
| No prescription or no fill | Which company refunds which payment, the cutoff, and what's kept |
| Coverage | Cash price, and any reimbursement your plan has actually confirmed |
Source check: October 15, 2026. Page: https://peptidecareindex.com/sermorelin/access/.
Is it legal to buy sermorelin online?
It can be, but a prescription alone is not the whole legal test. The patient route described here starts with an authorized prescriber and a pharmacy able to supply the exact preparation under the applicable compounding and state requirements. FDA's records identify sermorelin acetate as a component of approved drugs; that matters to the ingredient analysis, but it does not clear every product or seller. Buying "research use only" vials for yourself is not that route. (503A conditions; FDA's ingredient record)
What changed, and what didn't
Sermorelin was once an FDA-approved medicine called Geref. It isn't sold anymore, but FDA later confirmed it wasn't pulled for safety or effectiveness reasons. Neither fact makes today's compounded products FDA-approved.
Table 5. Sermorelin's FDA record, 1990 to 2026
| Date | What happened | What it means for buying today | Source |
|---|---|---|---|
| Dec 28, 1990 | FDA approves Geref (sermorelin acetate) injection, equivalent to 0.05 mg base per ampule (NDA 19-863) | An exact diagnostic injection product is approved—not every preparation containing the ingredient | 78 FR 14095 |
| Sep 26, 1997 | FDA approves Geref injection, equivalent to 0.5 mg and 1.0 mg base per vial (NDA 20-443), for children with growth hormone deficiency | The treatment version is approved | 78 FR 14095 |
| June 18, 2009 | Both approvals withdrawn | Withdraws those Geref approvals; the historical event alone is not a search for every later approval | 78 FR 14095 |
| Mar 4, 2013 | FDA determines Geref wasn't withdrawn for safety or effectiveness reasons | Leaves room for a future approved generic. Not an approval of anything sold now. | 78 FR 14095 |
| Mar 21, 2025 | The FDA 503B nominations document dated this day lists sermorelin acetate in Category 1 and marks it as a component of FDA-approved drugs | A dated ingredient/list record—not finished-product approval or the date of first classification | FDA 503B list |
| Checked Oct 15, 2026 | Sermorelin doesn't appear in FDA's 503A nominations categories, in the May 14, 2026 document, including its Category 2 (substances FDA says raise significant safety risks) | Absence from this nominations document is not a safety clearance or a finding about every other FDA action | FDA 503A list |
| Checked Oct 15, 2026 | Current Drugs@FDA records show the Geref diagnostic and treatment entries as discontinued | No currently marketed Geref product is established by those records; a compounded offer does not inherit the approvals | NDA 019863; NDA 020443 |
For the broader history of which peptides are and aren't approved, see our FDA-approved peptides list.
What "compounded" means for you
Compounding means combining, mixing or altering ingredients to make a medication for a medical need. A pharmacy is one setting; the rules also cover certain physician compounding and outsourcing facilities. FDA says compounded drugs aren't FDA-approved, which means FDA doesn't check their safety, effectiveness, or quality before they're sold (FDA).
So a prescription doesn't pass Geref's old approval to today's product. Two vials can both say "sermorelin" and come from very different processes. That's why the preparing pharmacy's name, its license, and its quality record are part of the purchase check—not a substitute for product-specific evidence.
Two federal compounding frameworks matter here:
- 503A pharmacies compound for identified patients within a prescription-based framework; limited anticipatory compounding is also allowed under stated conditions. State boards have primary oversight of state-licensed pharmacies, with FDA authority also applying.
- 503B outsourcing facilities register with FDA and are subject to current good manufacturing practice requirements. Federal law allows them to compound with or without prescriptions for identified individual patients; that is not permission for a research seller to sell prescription medicines as patient care. Applicable state requirements still need checking.
Sources: FDA's explanation; section 503A; section 503B.
Neither type makes the product FDA-approved.
Where sermorelin sits in FDA's compounding records
Section 503A's bulk-ingredient conditions are ordered, not three interchangeable shortcuts. When an applicable USP or NF monograph exists—a published quality standard—the ingredient must comply with it and the applicable compounding chapter. Without a monograph, being a component of an approved drug is another pathway. If neither applies, the ingredient must appear on the FDA list developed through regulation. Other conditions, including ingredient sourcing and valid certificates of analysis, still apply. A nominations category is not that final list. (FDA; 21 U.S.C. 353a(b))
FDA's 503B list marks sermorelin acetate as a component of FDA-approved drugs. It also places it in Category 1, which on that list means "under evaluation" for outsourcing facilities (FDA 503B list, updated Mar 21, 2025). Sermorelin does not appear in FDA's separate 503A nominations categories document, updated May 14, 2026, which we text-searched and visually checked.
Here's what that does and doesn't settle:
- It settles what those records say: the 503B document marks the ingredient as a component of approved drugs, and the May 14, 2026 503A nominations document has no sermorelin entry. That absence is not an FDA determination that sermorelin or a particular preparation is safe.
- It doesn't settle which basis a particular pharmacy relies on for its particular preparation, or whether that pharmacy follows every other rule. A 503B category isn't proof of a 503A pharmacy's basis.
The practical move is simple: ask the dispensing pharmacy which basis it relies on for your exact preparation, then check its license. These records don't support calling every sermorelin offer either "approved" or "banned."
Sermorelin Access Check: buying it, requirement by requirement
Each finding below applies to one requirement, not to a seller as a whole. "Supported" means the cited evidence supports that specific finding within the stated check. It isn't a safety badge.
Table 6. Peptide Care Access Check: buying compounded sermorelin in the U.S. Checked October 15, 2026. A source review, not legal advice. No pharmacy-law specialist has reviewed it.
| Requirement | Finding | Evidence | What we checked | Next question | What would change this |
|---|---|---|---|---|---|
| Geref is a currently marketed FDA-approved sermorelin product | Contradicted | Current Geref entries are discontinued; historical approvals withdrawn June 18, 2009 (FDA diagnostic record; treatment record; history) | Read the current product entries and historical notice | Is the offer compounded, and by which pharmacy? | A relevant new FDA product/marketing record |
| The advertised compounded product is FDA-approved | Contradicted | Compounded drugs aren't FDA-approved (FDA) | Read FDA's compounding Q&A and the offers' compounded descriptions | Is a different, exact approved finished product being offered? | The offer changing to a documented approved product |
| FDA's 503B document identifies sermorelin acetate as a component of FDA-approved drugs | Supported | Two-asterisk mark and key in the document dated Mar 21, 2025 (FDA) | Read the category heading/key on printed p. 3 and visually checked the ingredient on p. 6 | Which basis does your pharmacy cite? | FDA revising the relevant record |
| Sermorelin appears in Category 2 of the May 14, 2026 503A nominations document | Contradicted for this list-entry claim only | No sermorelin entry in that document (FDA) | Text search and visual check of the seven-page document, including Category 2 on p. 3 | What other source addresses the exact preparation's risks or access? | A revised list or other relevant record; absence itself is not a safety finding |
| A 503B category proves a 503A pharmacy's basis for its preparation | Not applicable | The frameworks have different conditions (503A; 503B) | Compared the applicable statutory conditions | Which 503A pathway does the pharmacy rely on? | Evidence specific to that pharmacy's framework |
| Section 503A uses an identified-patient, prescription-based framework | Supported | 21 U.S.C. 353a(a), including its limited anticipatory-compounding provision | Read the statute; did not apply it to a specific pharmacy's operations | Who writes the prescription, and are they authorized in your state? | A change in the applicable law or facts; 503B is a separate framework |
| Your order's pharmacy is named and meets applicable state requirements | Unresolved — differs by offer | Bayan names Olympia; CareFirst is named; Love My Peptides names Optimal Balance Pharmacy in its policy; Rx Peps Direct gives a location, not a name | Read the public disclosures; no individual license or order-specific fulfillment checks performed | What's the exact dispensing/preparing entity and its applicable license information? | An identified entity and dated, relevant licensing/fulfillment evidence |
| The seller's page consistently describes what you're buying | Conflicting — specific public terms | Brello: two renewal intervals and a semaglutide FAQ on its sermorelin page. Hone: $175 on its product page versus $130 estimated on its Premium help page. | Compared the product-specific wording and applicable help pages | Which product, quantity and terms govern this order? | An unambiguous corrected page or order-specific written clarification |
| The full cost and refund exposure are published for each compared order | Unresolved where fields remain missing | See Tables 1 and 4 and their linked first-party records | Read offers and the selected policies identified in those tables | Ask for the completed payment worksheet | Documented amounts, charge timing and applicable refund conditions |
| A "research use only" listing supplies a patient-care access basis | Not applicable | Research-use labeling is not prescribing/dispensing authorization; FDA's Xcel letter addresses an actual seller | Read the FDA letter; did not audit every research seller | Use a clinical/pharmacy route for a patient question | A different, documented patient-care offer would need its own check |
Injection, nasal spray, troche, or lozenge: are they the same purchase?
No. Injection, nasal, and mouth-dissolving preparations are different purchases. The human studies checked here do not establish equivalence between today's marketed forms. Geref's records concern injections, and a 1993 nasal study concerns its own study preparation—not today's advertised spray. Match the exact form before you compare prices.
Table 7. Sermorelin forms sold today vs the evidence behind them Offers checked October 15, 2026. Source check limited to Geref records, the two original study abstracts linked below, and targeted searches for sermorelin/GHRH 1-29 with troche, lozenge, sublingual and buccal terms. This is not a full literature review or a finding that no other studies exist.
| Form | Examples in Table 1 | Human evidence checked | What it does and doesn't show | Question to ask |
|---|---|---|---|---|
| Injection under the skin | AgelessRx, Bayan, Brello, Hone, Love My Peptides, Rx Peps Direct | Historical Geref injection records; an original six-week GHRH 1-29 study in 11 older men used subcutaneous injections (Vittone et al., 1997). Diagnostic IV administration is a separate route. | Some injected-form human evidence exists. It doesn't prove every current injection's adult anti-aging benefit or equivalence to another form. | What strength and total amount am I getting, and what evidence matches the proposed use? |
| Nasal spray | AgelessRx | In a 1993 study, 30 healthy men aged 19–43 received IV or intranasal GHRH(1-29)-NH2. The abstract reports a growth-hormone response and nasal bioavailability of 3–5% for that study preparation (Wilton et al.). | Acute pharmacology, not proof of adult wellness benefits or the absorption of a currently marketed spray. Do not use the study to convert routes or doses. | What evidence supports this exact spray and its intended benefit? |
| Troche (dissolves in the mouth) | CareFirst | No matching human trial verified in this review | The checked sources do not establish injection-equivalent absorption or clinical benefit; this is not proof that no study exists. | What evidence supports this form? |
| Lozenge | Strut | No matching human trial verified in this review | Mouth-dissolving products must not borrow injected-form results; no equivalence established here. | What's the strength, and what evidence supports it? |
| Blend (sermorelin plus another peptide) | None in Table 1 | Not evaluated here | Evidence for sermorelin alone doesn't cover a blend's other ingredients | What's every active ingredient and amount? |
Does a pricier form work better?
Price doesn't tell you anything about benefit. The studies checked here do not compare the marketed offers in Table 1 head to head.
The human research on sermorelin is real but narrow. It includes historical diagnostic and pediatric uses and small adult studies. In the six-week study of 11 men aged 64–76, two of six strength measures and one endurance test improved, while the measured body-composition outcomes did not change. This was a before-and-after study without a placebo comparison, not proof that the drug caused every change (Vittone et al.). That isn't the same question as whether a lozenge helps an adult build muscle or sleep better. If a seller claims a result, ask for the study that matches the molecule, the form, the people, and the outcome. A hormone level, a mechanism, a customer survey, and a clinical result are four different kinds of support. For the evidence side by side with other peptides, see our peptide comparison chart.
Sermorelin peptide buy checklist: 10 things to confirm before you pay
Before you pay, confirm the prescriber, the pharmacy, the product, and the money. Each item says how to check it yourself. If a seller won't answer an item in writing, treat that as your answer.
Table 8. Ten things to confirm before paying for sermorelin
| # | Confirm | How to check it |
|---|---|---|
| 1 | A licensed clinician reviews you and writes the prescription | Ask for the clinician's name and state. Look them up on your state's medical or nursing board site. |
| 2 | The pharmacy's name | Ask in writing. "Our partner pharmacy" isn't a name. |
| 3 | The relevant state licenses, plus FDA registration when a 503B facility is claimed | Use FDA's state-license locator and, where applicable, FDA's outsourcing-facility register. Match the exact legal entity and address. Neither record alone authorizes every product. |
| 4 | The exact product: ingredient/salt, form, strength, total amount | It should match the label you receive. |
| 5 | The amount charged today | Get a number, not "per month." |
| 6 | What renews, when, and at what price | Look for "billed in full," "auto-refill," "commitment," or "protocol." |
| 7 | How to cancel, and how far ahead | Get the notice period in writing. |
| 8 | What you get back if you're not prescribed, or the pharmacy can't fill it | Ask before paying any review fee. |
| 9 | Which labs are required, and who bills them | "Labs not mentioned" isn't "no labs." |
| 10 | Shipping and storage | Ask whether it ships cold and what to do if it arrives warm or damaged. |
Source check: October 15, 2026. Page: https://peptidecareindex.com/sermorelin/access/.
A message you can copy and send
Before I authorize payment, please confirm the exact sermorelin formulation, route, strength, and supplied quantity; the prescribing service and the dispensing pharmacy; and whether that pharmacy can fill and ship this prescription to my state. Please itemize the amount due now, any required labs or follow-up visits, shipping, and the next charge and renewal date. Please tell me which compounding basis the pharmacy relies on for this exact preparation. What happens to each payment if no prescription is issued, the pharmacy can't fill it, or I cancel? And who do I contact if a refill is interrupted or a shipment arrives damaged?
Red flags that should stop the purchase
- "No prescription needed"
- "FDA-approved compounded sermorelin"
- "For research use only" sold alongside dosing tips
- Payment only by crypto, payment apps, or gift cards
- No named company, no U.S. address, or no pharmacist you can reach
- A certificate of analysis offered as proof that it's safe for people
- Prices that seem too good to be true, or "today only" pressure
FDA lists many of the same warning signs for online pharmacies. Its safer-pharmacy checks include a prescription requirement, a U.S. address and phone number, a licensed pharmacist available, and state-board licensing (FDA BeSafeRx).
You've got the questions; the hard part is getting straight answers about one specific offer. Peptide Care Index's Find My Peptide Path tool walks you through the questions: who takes each payment, who prescribes, which pharmacy fills the order, whether your state is served, and what happens to your money if nothing is prescribed. It doesn't assess eligibility or match you with a provider; it helps you see what's still unanswered before you pay.
Can you buy sermorelin without a prescription?
Not through the prescription-dispensing route described here. A site offering "research use only" sermorelin is not offering a patient prescription just because it takes your order. FDA has sent warning letters to sellers using research disclaimers alongside human-use claims. The label doesn't establish pharmacy licensing, and a purity-only test report doesn't establish sterility or clinical safety. (FDA's Xcel letter; FDA online-pharmacy guidance)
What FDA has done. Our warning-letter register contains 18 selected FDA letters to online research-peptide sellers from 2024 to 2026. One, sent to Xcel Research LLC on December 10, 2024, lists sermorelin among the products FDA cited. FDA also issued letters to Peptide Partners, Peak Performance Peptides, and NuScience Peptides on August 24, 2026. Those three letters do not name sermorelin; they are not a new blanket sermorelin ban.
How big this market is. Forbes reported on September 25, 2026 that one tracking site counted 526 online storefronts selling sermorelin as of September 20. That tracker accepts affiliate links from sellers, so treat the number as a rough count from an interested party (Forbes).
What a certificate of analysis (COA) proves, and what it doesn't. A COA records specified tests on an identified sample or batch; it can come from a manufacturer or testing laboratory.
- It can support: the reported identity, purity or amount, when those tests were actually performed and the report and sample are authentic. A report can also include sterility or bacterial-endotoxin testing when those separate tests were done.
- It can't establish by a purity percentage alone: sterility, endotoxin limits, clinical safety, FDA approval, lawful patient supply, or that your vial is the same material that was tested. A passing sample result is not a guarantee about every vial.
Sterility and pyrogen testing are distinct requirements where applicable, not another name for chemical purity (21 CFR 211.167). We did not inspect original lot-specific laboratory reports for these offers.
For what peptide testing data does and doesn't show, see our peptide purity testing statistics.
Reported harms. Forbes described a woman who said she went into anaphylactic shock, a severe allergic reaction, after injecting sermorelin bought from a research-use website in July 2025. She needed emergency treatment. Forbes also described a reaction in someone who got sermorelin through a telehealth service in 2025. Forbes notes the products weren't tested, so the cause can't be known (Forbes). These are reports, not proof of what caused them. A research seller is not a substitute for a dispensing pharmacist or emergency care when something goes wrong.
Why research sites look cheaper. We don't publish their prices. They aren't a patient source, and their price doesn't buy the same thing: no prescriber, no dispensing pharmacist, no label meant for you.
When your order arrives, or a refill looks different
Check every order against its label and its bill, even refills. Don't assume this one matches the last. If a shipment looks wrong or damaged, call the dispensing pharmacist before you use it.
Compare these each time:
- The pharmacy's name
- The form, strength, and amount
- The charges
- The storage directions
- The pharmacy's beyond-use date (the date after which it shouldn't be used)
A broken, improperly labeled, expired, or unexpected package is among FDA's online-pharmacy warning signs (FDA BeSafeRx). If the package is warm despite cold-storage instructions, ask the dispensing pharmacist about that exact product and shipping period. Ask the pharmacy what to do rather than guessing a storage rule from another product. A missed refund window is never a reason to use a product you're worried about. For general storage information, see our peptide storage chart.
Safety before you start
Mayo Clinic's injection-route information lists pain, redness, or swelling where sermorelin is injected as more common effects. Flushing, headache, and dizziness are listed as rare effects (Mayo Clinic). Those frequency labels are not measured rates for every current compounded injection, spray or lozenge. Serious allergic reactions after products sold as sermorelin have also been reported, as discussed above.
Get emergency care right away (call 911) for trouble breathing, swelling of the tongue or throat, collapse, or fainting after a dose, especially with hives or other signs of a severe allergic reaction. Don't wait for the symptoms to pass. Use a prescribed epinephrine autoinjector as directed if you have one, and still get emergency care (Mayo Clinic: anaphylaxis).
Talk it through with a clinician first if any of these apply to you:
- You've had cancer. Tell the clinician about the diagnosis, treatment and any current follow-up.
- You have an underactive thyroid. Mayo Clinic's sermorelin drug information includes a thyroid caution.
- You're pregnant, planning a pregnancy or breastfeeding.
- You're under 18. Children's growth problems belong with a pediatric hormone specialist, not an adult telehealth service.
Licensed pharmacies have recalled sermorelin products too. In 2016, a compounding pharmacy recalled a sermorelin/GHRP-6 blend after a sterility failure; FDA noted it in a 2017 warning letter (FDA). Olympia Pharmacy's March 10, 2022 voluntary recall covered 11 lots across seven compounded products because of out-of-specification results. It included two sermorelin acetate 9 mg lots, D44026 and F42104—not a recall of every current sermorelin product. The announcement said Olympia had received no adverse-event reports related to that recall at the time (FDA-hosted recall announcement). These are historical, product- and lot-specific actions, not findings about today's offers. You can search FDA's recall records for your pharmacy and product, and see our peptide recalls and peptide side effects chart.
How we checked
We read FDA records, federal law, each seller's own offer, and the refund or membership policies identified below on October 15, 2026, then did the arithmetic ourselves. We didn't buy sermorelin, test a product, check an individual license, or confirm terms with any seller.
Peptide Care Index is the independent decision and access index for peptide care—helping you understand the route, the cost, the evidence, and the next step before you pay.
What we actually checked
- Sources: current and historical Geref records; FDA's compounding documents, online-pharmacy guidance, warning letters and recalls; federal law; all nine offer pages; and the specific policy/help pages linked in the tables. Forbes reporting supplies context, not a clinical or legal conclusion.
- Check dates and depth: public sources were checked October 15, 2026. The FDA nominations documents keep their own dates: May 14, 2026 for 503A and March 21, 2025 for 503B. We inspected their relevant pages. The two studies were checked through their original abstracts, not full-paper reviews. The form search was targeted, not a complete literature review.
- What's provider-published: every price, plan term, and refund rule in Tables 1, 3, and 4. Our subtotals and conditional examples are arithmetic, not checkout confirmations. Missing charges and source conflicts remain marked.
- Not done: no purchases, completed checkout tests, individual license checks, pharmacy inspections, product testing, or review by a pharmacy-law or clinical specialist.
- How offers were chosen and ordered: U.S. offers with inspectable public pages, covering different forms and payment models. Listed alphabetically. Not the whole market, not ranked, no scores.
- Findings: labeled with our Peptide Care Access Check: Supported, Contradicted, Unresolved, Conflicting, or Not applicable, each attached to one requirement. Our editorial standards explain corrections and AI assistance; the publisher profile identifies responsibility for this source-based work.
Questions buyers still ask
Can my regular doctor prescribe sermorelin?
Yes, an authorized prescriber can consider it if they decide it's appropriate for you; not every doctor offers it. They'd send the prescription to a pharmacy that can fill the exact preparation within the applicable rules (21 U.S.C. 353a). That can skip a telehealth membership entirely, and you can use the payment worksheet above with the pharmacy.
Is sermorelin the same as HGH?
No. Sermorelin signals your pituitary gland to release your own growth hormone; it isn't growth hormone (Mayo Clinic). That matters when you're buying: 21 U.S.C. 333(e) restricts knowing distribution, or possession with intent to distribute, human growth hormone for human use outside its stated disease/recognized-condition, authorization and physician-order conditions. Don't assume a prescription permits HGH for any purpose, or apply an HGH rule to a different molecule without checking it. Be wary of any seller that blurs the two.
Can athletes use sermorelin?
Sermorelin is prohibited at all times for athletes covered by the WADA rules—not only during competition. The 2026 Prohibited List, section S2.2.4, names it among growth hormone–releasing factors. A prescription is not an exemption. Check your governing body's rules and any required therapeutic use exemption before use; USADA says a sermorelin exemption is highly unlikely. See our WADA-banned peptides list.
Is research-site "sermorelin" the same molecule?
It may carry the same name, but the name alone doesn't confirm the vial's contents, amount, or sterility. A genuine test report supports only the tests and sample it identifies, and a research-use label does not establish patient dispensing or clinical suitability. See the COA explanation above and FDA's Xcel Research letter.
Does it ship cold?
It depends on the form and the pharmacy. CareFirst says its troches need ice packs, at $19.95 extra per order, and Rx Peps Direct ships overnight. Ask your pharmacy how your exact product ships and how to store it when it arrives.
What if I'm turned down after paying for a visit?
It depends on the seller and which charge you paid. Brello refunds in full when its clinician declines treatment and no prescription is issued. AgelessRx says it doesn't charge for the prescription until you're approved. Rx Peps Direct keeps its $39 review once review begins; Love My Peptides keeps a visit fee once the visit begins, even if medication is declined, but does not charge for medication that isn't prescribed. The reviewed Bayan, Hone and Strut sources did not settle their denial-refund outcomes. CareFirst requires an existing prescription, so your prescriber's fee is a separate question. Table 4 links the applicable policies.
Your next step: settle the offer before you pay
You know the prescription route and its remaining checks, what nine real offers advertise, and where the traps are: locked terms, unstated totals, and fees you lose if you're turned down. You don't need another list of sellers now. You need answers about the one offer in front of you.
Keep your quote and the pharmacy's name handy. Peptide Care Index's Find My Peptide Path tool puts the dated sermorelin access summary, the provider check, the fee checklist, and copyable questions in one place, so you can see what still needs an answer before you pay. Free to use. No signup required. It doesn't assess eligibility or guarantee a prescription.
Sources
The linked public sources were checked October 15, 2026, at the reading depth described above. Source publication and update dates are separate from our check date. Provider pages are the sellers' own claims; an unresolved term does not become confirmed because its page was read.
Federal records and law
- Federal Register, 78 FR 14095–14096 (Mar 4, 2013): Determination that GEREF was not withdrawn for safety or effectiveness
- FDA: Bulk drug substances nominated under section 503B, updated Mar 21, 2025
- FDA: Bulk drug substances nominated under section 503A, updated May 14, 2026
- FDA: Bulk drug substances used in compounding under section 503A
- FDA: Compounding and the FDA: questions and answers
- FDA BeSafeRx: Considering an online pharmacy? and Locate a state-licensed online pharmacy
- 21 U.S.C. 353a, pharmacy compounding
- FDA: Warning letter, Town and Country Compounding (2017)
- FDA: Olympia Pharmacy voluntary recall of seven compounded products
- FDA Drugs@FDA: current Geref NDA 019863 and NDA 020443 product/marketing entries
- 21 U.S.C. 353b, outsourcing-facility conditions; 21 U.S.C. 333(e), human growth hormone distribution restriction
- FDA: registered outsourcing facilities—lookup resource, not an individual provider verification
- 21 CFR 211.167: special testing requirements—distinct sterility/pyrogen tests where the regulation applies
- FDA: Xcel Research LLC, Dec 10, 2024
- FDA: Peptide Partners, Aug 24, 2026; Peak Performance Peptides, Aug 24, 2026; NuScience Peptides, Aug 24, 2026
Provider pages
- AgelessRx: sermorelin injection, sermorelin nasal spray, FAQ
- Bayan Health: sermorelin injection
- Brello: compounded sermorelin, refund policy
- CareFirst Specialty Pharmacy: sermorelin compounded
- Hone Health: sermorelin
- Love My Peptides: pricing
- Rx Peps Direct: sermorelin, refund policy
- Strut Health: oral sermorelin
- Bayan Health: FAQ and terms of service—review did not resolve the denial-refund question
- Hone Health: men's Premium plan, membership overview and membership FAQ
- Love My Peptides: refund and cancellation policy, September 2026
- Strut Health: FAQ, cancellation help and refund policy, dated September 21, 2021
Research, clinical guidance and reporting
- Wilton P, et al. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10–15. Original PubMed abstract; publisher DOI. Original abstract read; full paper not reviewed.
- Vittone J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997;46(1). Original PubMed abstract; publisher DOI. Original abstract read; full paper not reviewed.
- Mayo Clinic: sermorelin injection-route drug information, updated Feb 1, 2026; anaphylaxis symptoms and emergency care, Apr 16, 2025
- WADA: 2026 Prohibited List, section S2.2.4, effective January 1, 2026; USADA's sermorelin and exemption guidance
- Forbes, Sept 25, 2026 (updated Oct 8): These fitness fans took bootleg peptides. It landed them in the hospital. Attributed reporting, not a tested-product causality finding or an independently repeated seller census.